Compare BNGO & VCIG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BNGO | VCIG |
|---|---|---|
| Founded | 2003 | 2013 |
| Country | United States | Malaysia |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Diversified Commercial Services |
| Sector | Industrials | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.6M | 12.5M |
| IPO Year | 2018 | 2022 |
| Metric | BNGO | VCIG |
|---|---|---|
| Price | $1.16 | $1.44 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $6.33 | N/A |
| AVG Volume (30 Days) | 257.0K | ★ 828.2K |
| Earning Date | 03-23-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 94.50 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $12,000,735.00 | N/A |
| Revenue This Year | $25.49 | N/A |
| Revenue Next Year | $48.03 | N/A |
| P/E Ratio | ★ N/A | $1.81 |
| Revenue Growth | ★ 26.26 | N/A |
| 52 Week Low | $1.06 | $0.20 |
| 52 Week High | $5.50 | $23.40 |
| Indicator | BNGO | VCIG |
|---|---|---|
| Relative Strength Index (RSI) | 47.01 | 43.32 |
| Support Level | $1.07 | $0.75 |
| Resistance Level | $1.18 | $2.18 |
| Average True Range (ATR) | 0.07 | 0.27 |
| MACD | 0.01 | -0.22 |
| Stochastic Oscillator | 13.51 | 3.65 |
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.
VCI Global Ltd is a holding company. The principal activities of the Company and its subsidiaries are the provision of business Strategy consultancy and technology development. The firm organized its consulting services into three main segments: Business Strategy Consultancy; Technology development, solutions and consultancy; and Others. It derives the majority of its revenue from the Business Strategy Consultancy segment, which focuses on listing solutions, investor relations, and boardroom strategies consultancy.